Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: Reinforcement of the heterogeneity of the syndrome

Leukemia Research

Volumn 27, Issue 9, 2003, Pages 775-782

  Steensma, David P ^a   Tefferi, Ayalew ^a   Li, Chin Yang ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chronic myelomonocytic leukemia; Myelodysplastic syndrome; Splenic histopathology

Indexed keywords

CD68 ANTIGEN; PHOSPHOGLUCOMUTASE;

ADULT; AGED; ARTICLE; CELL DESTRUCTION; CELL INFILTRATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; FOAM CELL; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOCYTE; MORBIDITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SPLEEN DISEASE; SPLENECTOMY; SPLENOMEGALY; SURGICAL MORTALITY; SURGICAL RISK; SYNDROME; SYNDROME DELINEATION; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037503742     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00006-7     Document Type: Article

References (25)

1. Chronic myelomonocytic leukemia: single entity or heterogeneous disorder? A prospective multicenter study of 100 patients. Groupe Francais de Cytogenetique Hematologique. Cancer Genet Cytogenet 1991;55(1):57-65.
2. Michaux J.L., Martiat P. Chronic myelomonocytic leukaemia (CMML) - a myelodysplastic or myeloproliferative syndrome? Leuk. Lymphoma. 9(1-2):1993;35-41.
3. Bennett J.M.et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) Co-operative Group. Br. J. Haematol. 33(4):1976;451-458.
4. Bennett J.M.et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51(2):1982;189-199.
5. Bennett J.M.et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid. Br. J. Haematol. 87(4):1994;746-754.
6. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 100(7):2002;2292-2302.
7. Germing U.et al. Problems in the classification of CMML - dysplastic versus proliferative type. Leuk. Res. 22(10):1998;871-878.
8. Onida F.et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 99(3):2002;840-849.
9. Voglova J.et al. Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia - distinct subgroups or two stages of the same disease? Leuk. Res. 25(6):2001;493-499.
10. Harris N.L.et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Ann. Oncol. 10(12):1999;1419-1432.
11. Kraus M.D.et al. Splenic pathology in myelodysplasia: a report of 13 cases with clinical correlation. Am. J. Surg. Pathol. 22(10):1998;1255-1266.
12. Hofmann W.K.et al. Myelodysplastic syndromes: clinical features. Semin. Hematol. 33(3):1996;177-185.
13. Kraemer D.et al. Splenectomy in patients with mixed myelodysplastic/myeloproliferative disease. Ann. Hematol. 81(6):2002;308-311.
14. Bourgeois E.et al. Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases. Leukemia. 15(6):2001;950-953.
15. Yam L.T., Li C.-Y., Crosby W.H. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 55(3):1971;283-290.
16. Ishihara T., Matsumoto N., Uchino F. Foamy histiocytes in the spleen associated with idiopathic thrombocytopenic purpura. Acta Pathol. Jpn. 24(2):1974;273-284.
17. Tefferi A.et al. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood. 95(7):2000;2226-2233.
18. Enright H., Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk. Lymphoma. 24(5-6):1997;483-489.
19. Okamoto T.et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int. J. Hematol. 66(3):1997;345-351.
20. George J.N. Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes? Leuk. Res. 26(9):2002;789-790.
21. Mainwaring C.J., Shutt J., James C.M. Not all cases of idiopathic thrombocytopenic pupura are what they might first seem. Clin. Lab. Haematol. 24(4):2002;261-262.
22. Espinosa G.et al. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin. Rheumatol. 21(4):2002;309-313.
23. Yahata N.et al. Chronic myelomonocytic leukemia in a patient with antiphospholipid syndrome: first case report. Leuk. Res. 21(9):1997;889-890.
24. Sawyers C.L. Chronic myeloid leukemia. N. Engl. J. Med. 340(17):1999;1330-1340.
25. Valent P.et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk. Res. 25(7):2001;603-625.